 |
|
Concerns Regarding Universal Varicella ImmunizationTime Will Tell
Lori L. MacFarlane, PharmD, BCPS;
Melissa L. Sanders, PharmD;
Peter J. Carek, MD, MS
Arch Fam Med. 1997;6(6):537-541.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Office of Disease Prevention, US Department of Health and Human Services. The Clinician's Handbook of Preventive Services. Alexandria, Va: International Medical Publishing Inc; 1994.
2. Drwal-Klein LA, O'Donovan CA. Varicella in pediatric patients. Ann Pharmacother. 1993;27:938-949.
ABSTRACT
3. Committee on Infectious Disease. Recommendation for use of live-attenuated varicella vaccine. Pediatrics. 1995;95:791-796.
FREE FULL TEXT
4. Anonymous. Varicella vaccine. Med Lett. 1995;37:55-56.
5. Doctor A, Harper M, Fleisher GR. Group A-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics. 1995;96:428-433.
FREE FULL TEXT
6. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45 (RR-11):1-36.
PUBMED
7. Watson B, Gupta R, Randall T, et al. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis. 1994;169:197-199.
PUBMED
8. Carmichael JK. Treatment of herpes zoster and postherpetic neuralgia. Am Fam Physician. 1991;44:203-210.
PUBMED
9. Gershon AA. Varicella vaccine: still at the crossroads. Pediatrics. 1992;90:144-148.
FREE FULL TEXT
10. Olin BR, ed. Drug Facts and Comparisons. St Louis, Mo: JB Lippincott; 1995:467j. 11. Zimmerman RK. Varicella vaccine: rationale and indications for use. Am Fam Physician. 1996;53:647-651.
PUBMED
12. Plotkin SA. Varicella vaccine. Pediatrics. 1996;97:251-253.
FREE FULL TEXT
13. Virella G. The humoral immune response and its induction by active immunization. In: Virella G, ed. Introduction to Medical Immunology. New York, NY: Marcel Dekker Inc; 1993:213-232. 14. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (Varivax) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics. 1991;87:604-610.
FREE FULL TEXT
15. Gershon AA, Steinberg SP, LaRussa P, et al. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis. 1988;158:132-137.
PUBMED
16. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason: twenty-year follow-up of protective immunity of the OKA strain live varicella vaccine. Pediatrics. 1994;94:524-526.
FREE FULL TEXT
17. Asano Y, Nagai T, Miyata T, et al. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics. 1985;75:667-671.
FREE FULL TEXT
18. Arbeter AM, Starr SE, Plotkin SA, et al. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78(suppl):748-756.
FREE FULL TEXT
19. Arbeter AM, Starr SE, Prelub SR, et al. Varicella vaccine trials in healthy children. AJDC. 1984;138:434-438.
PUBMED
20. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271:375-381.
FREE FULL TEXT
21. White CJ. Varicella vaccine reflux. Pediatrics. 1992;89:354.
FREE FULL TEXT
22. Guess HA, Broughton DD, Melton LH, Kurtland LT. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics. 1985;76:512-517.
FREE FULL TEXT
23. Hardy I, Gershon AA, Steinberg SP, LaRussa P, and the Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine. N Engl J Med. 1991;325:1545-1550.
ABSTRACT
24. Halloran ME, Cochi SL, Lieu TA, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994;140:81-101.
FREE FULL TEXT
25. Preblud SR, Orenstein WA, Koplan JP, et al. A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J. 1985;61:17-22.
26. Huse DM, Meissner HC, Lacey MJ, et al. Child-hood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr. 1994;124:869-874.
PUBMED
27. Pacificare adds Varivax to immunization schedule, clarifies guideline. F-D-C Reports—'The Pink Sheet. 'Chevy Chase, Md: F-D-C Reports Inc; April 15, 1996. T & G 13-14.
|
